Playing with a heavily bandaged left thumb, the gallant half-century from the Indian captain could not save India from a consecutive ODI series defeat in Bangladesh as Mustafizur Rahman defended 20 runs from the last over to secure a win for his team.
Miraz was top scorer for Bangladesh with an unbeaten 100 of 83 balls while Mahmudullah played a crucial knock of 77 runs of 96 deliveries. For India, Washington Sundar bagged three while Mohammed Siraj and Umran Malik claimed two wickets each.
Recently, the Indian government has raised concerns about growing Khalistani divisive activities in multiple capital cities of Australia and one of the officials in the meeting said, "Allegations of some overseas players entering into Australia and running a malicious campaign with elements
After being bowled out for 137, the Jaffna Kings restricted the Galle Gladiators to 113/9 in their 20 overs. For Jaffna Kings, Vijayakanth Viyaskanth (2/20) and Binura Fernando (3/22) were the picks of the bowlers
Chahar was en route from New Zealand to Dhaka for the three-match ODI series between India and Bangladesh. The pacer travelled to Bangladesh to join the Indian team for the three-match ODI series, which begins on Sunday.
Anaplastic large-cell lymphoma (ALCL), a rare malignancy, has increased in frequency during the past several years, presumably as a result of the rising popularity of textured breast implants.
India has notably tried many players in the decade of 2020s. A lot of players have been tried after delivering good performances in IPL. These players include Shahbaz Ahmed, Umran Malik, Arshdeep Singh, Suryakumar Yadav, Ruturaj Gaikwad, Venkatesh Iyer, Nitish Rana, Deepak Hooda etc
Earlier, on Wednesday, the Pakistani delegation comprises of State Minister for Petroleum Musadik Malik, joint secretary and officials of the Pakistan Embassy in Moscow, asked for a discount during talks in Moscow.
Bengaluru (Karnataka) [India], November 30 (ANI/PRNewswire): Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of its partner Vi